Practice Points in TGCT: Updates on Safe Use of Novel Systemic Options

Course Description

Understanding practical considerations with systemic therapy in tenosynovial giant cell tumor (TGCT) can be critical for safe delivery of therapy. In this activity, an expert medical oncologist provides a practical update on targeted treatment options for TGCT management, with a focus on safe delivery of care—including appropriate dosing, food effects, and safety considerations—based on the current clinical experience with approved CSF1R inhibitors.

Other Courses in this Series

Other Courses That May be of Interest

Scroll to Top